These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 29206660)

  • 1. Recent developments in systemic lupus erythematosus pathogenesis and applications for therapy.
    Lo MS; Tsokos GC
    Curr Opin Rheumatol; 2018 Mar; 30(2):222-228. PubMed ID: 29206660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly selective inhibition of Bruton's tyrosine kinase attenuates skin and brain disease in murine lupus.
    Chalmers SA; Wen J; Doerner J; Stock A; Cuda CM; Makinde HM; Perlman H; Bosanac T; Webb D; Nabozny G; Fine JS; Klein E; Ramanujam M; Putterman C
    Arthritis Res Ther; 2018 Jan; 20(1):10. PubMed ID: 29370834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From mechanism to therapies in systemic lupus erythematosus.
    Paley MA; Strand V; Kim AH
    Curr Opin Rheumatol; 2017 Mar; 29(2):178-186. PubMed ID: 28118202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant T Cell Signaling and Subsets in Systemic Lupus Erythematosus.
    Katsuyama T; Tsokos GC; Moulton VR
    Front Immunol; 2018; 9():1088. PubMed ID: 29868033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting lymphocyte signaling pathways as a therapeutic approach to systemic lupus erythematosus.
    Kyttaris VC; Tsokos GC
    Curr Opin Rheumatol; 2011 Sep; 23(5):449-53. PubMed ID: 21720246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MAP4K Family Kinases and DUSP Family Phosphatases in T-Cell Signaling and Systemic Lupus Erythematosus.
    Chuang HC; Tan TH
    Cells; 2019 Nov; 8(11):. PubMed ID: 31766293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small molecules in the treatment of systemic lupus erythematosus.
    Markopoulou A; Kyttaris VC
    Clin Immunol; 2013 Sep; 148(3):359-68. PubMed ID: 23158694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression profiling in the study of the pathogenesis of systemic lupus erythematosus.
    Qing X; Putterman C
    Autoimmun Rev; 2004 Nov; 3(7-8):505-9. PubMed ID: 15546798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging concepts in the molecular pathogenesis of systemic lupus erythematosus.
    Nambiar MP; Juang YT; Tsokos GC
    Arch Immunol Ther Exp (Warsz); 2002; 50(1):35-45. PubMed ID: 11916307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell signaling abnormalities in human systemic lupus erythematosus.
    Nambiar MP; Krishnan S; Tsokos GC
    Methods Mol Med; 2004; 102():31-47. PubMed ID: 15286379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bruton's tyrosine kinase in systemic lupus erythematosus.
    Liao HT; Tung HY; Tsai CY; Chiang BL; Yu CL
    Joint Bone Spine; 2020 Dec; 87(6):670-672. PubMed ID: 32473417
    [No Abstract]   [Full Text] [Related]  

  • 12. Aberrant T cell ERK pathway signaling and chromatin structure in lupus.
    Gorelik G; Richardson B
    Autoimmun Rev; 2009 Jan; 8(3):196-8. PubMed ID: 18723128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-17 in systemic lupus erythematosus: A comprehensive review.
    Li D; Guo B; Wu H; Tan L; Chang C; Lu Q
    Autoimmunity; 2015; 48(6):353-61. PubMed ID: 25894789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in systemic lupus erythematosus pathogenesis via mTOR signaling pathway.
    He J; Ma J; Ren B; Liu A
    Semin Arthritis Rheum; 2020 Apr; 50(2):314-320. PubMed ID: 31796213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mTOR signaling: a central pathway to pathogenesis in systemic lupus erythematosus?
    Fernandez D; Perl A
    Discov Med; 2010 Mar; 9(46):173-8. PubMed ID: 20350481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunometabolism in the pathogenesis of systemic lupus erythematosus: an update.
    Romo-Tena J; Kaplan MJ
    Curr Opin Rheumatol; 2020 Nov; 32(6):562-571. PubMed ID: 32826478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monogenic Lupus.
    Lo MS
    Curr Rheumatol Rep; 2016 Dec; 18(12):71. PubMed ID: 27812953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of signaling transducers and activators of transcription 1 and systemic lupus erythematosus.
    Liang Y; Xu WD; Yang XK; Fang XY; Liu YY; Ni J; Qiu LJ; Hui P; Cen H; Leng RX; Pan HF; Ye DQ
    Autoimmunity; 2014 May; 47(3):141-5. PubMed ID: 24437638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lithium in vitro enhances interleukin-2 production by T cells from patients with systemic lupus erythematosus.
    Kucharz EJ; Sierakowski SJ; Goodwin JS
    Immunopharmacol Immunotoxicol; 1993 Nov; 15(5):515-23. PubMed ID: 8301016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of STAT Signaling Pathways in the Pathogenesis of Systemic Lupus Erythematosus.
    Goropevšek A; Holcar M; Avčin T
    Clin Rev Allergy Immunol; 2017 Apr; 52(2):164-181. PubMed ID: 27216430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.